异物反应:新兴细胞类型和针对性治疗的考虑
Brenda Yang1, Natalie Rutkowski1, Jennifer Elisseeff1,2
1Translational Tissue Engineering Center, Wilmer Eye Institute and Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA. jhe@jhu.edu.
Biomaterials science
|October 31, 2023
概括
对生物材料的异体反应 (FBR) 涉及复杂的免疫细胞,超出了经典的介质. 了解T细胞,肌-免疫相互作用和衰老细胞可以改善植入物集成和愈合.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 组织工程是组织工程.
背景情况:
- 异物反应 (FBR) 是生物材料的一个重大挑战,导致慢性免疫反应和植入物隔离.
- 目前对FBR介质的理解尚不完整,需要探索各种细胞参与者.
- 调节对生物材料的免疫反应是提高组织修复和整合的关键.
研究的目的:
- 审查T细胞的新兴角色,肌体免疫细胞相互作用,以及FBR中的衰老细胞.
- 强调需要对这些细胞类型进行更深入的研究,以确定治疗点.
- 讨论影响人类FBR的因素,如模型,衰老,微生物群和性别差异.
主要方法:
- 文献综述侧重于最近对FBR细胞机制的研究.
- 分析特定细胞类型 (T细胞,衰老细胞) 和细胞与细胞相互作用的作用.
- 对人类FBR的翻译考虑的讨论.
主要成果:
- 新出现的证据表明,T细胞,肌体免疫相互作用和衰老细胞是FBR的关键,但被低估的贡献者.
- 这些细胞成分显著影响宿主对合成生物材料的反应.
- 了解这些异质反应对于设计下一代免疫调节材料至关重要.
结论:
- 对FBR中异质宿主细胞反应的全面理解对于提高生物材料性能至关重要.
- 针对新的细胞介质可以导致增强的植入物集成和减少纤维封装.
- 未来的研究应该专注于这些细胞参与者和人类特异性因素,以推进生物材料设计.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
01:27Cytotoxic T Cells-mediated Immune Response
933
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
933
01:36Humoral Immune Responses
72.8K
Overview
72.8K
01:40Cell-mediated Immune Responses
68.6K
Overview
68.6K
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K